Carcinoma, Ductal, Breast - 16 Studies Found
| Terminated |
: Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma : Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II : 2013-02-06 : Dietary Supplement: Vitamin D Subjects will be assigned to a dosage level between 600IU daily and 10,000 |
| Completed |
: Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ :
|
| Completed |
: Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1 : Invasive Ductal Breast Carcinoma : 2015-11-03 :
|
| Completed |
: Lumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT) :
: Radiation: Intraoperative Electron Radiotherapy Intraoperative Electron Radiotherapy (IOERT) is delivere |
| Recruiting |
: Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer : Ductal Breast Carcinoma In Situ : 2015-12-18 :
|
| Completed |
: G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer :
|
| Terminated |
: A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS) : Breast Carcinoma : 2005-09-12 :
|
| Completed |
: Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ : Breast Cancer : 2010-05-26 :
|
| Not yet recruiting |
: Tamoxifen Citrate or Afimoxifene in Treating Patients With Estrogen Receptor Positive Breast Cancer :
: 2016-12-14 : |
| Completed |
: Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection :
|